Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Fish and Richardson
Merck
Citi
Johnson and Johnson
Harvard Business School
Colorcon
US Department of Justice
Federal Trade Commission

Generated: August 23, 2017

DrugPatentWatch Database Preview

Methylprednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for methylprednisolone acetate and what is the scope of methylprednisolone acetate patent protection?

Methylprednisolone acetate
is the generic ingredient in six branded drugs marketed by Watson Labs, Pharmacia And Upjohn, Akorn, Sandoz Inc, Teva Pharms Usa, Bel Mar, and Sandoz, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are forty drug master file entries for methylprednisolone acetate. Fourteen suppliers are listed for this compound.

Summary for Generic Name: methylprednisolone acetate

Tradenames:6
Patents:0
Applicants:7
NDAs:17
Drug Master File Entries: see list40
Suppliers / Packagers: see list14
Bulk Api Vendors: see list37
Clinical Trials: see list1,315
Patent Applications: see list3,539
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:methylprednisolone acetate at DailyMed

Pharmacology for Ingredient: methylprednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
METHYLPREDNISOLONE ACETATE
methylprednisolone acetate
INJECTABLE;INJECTION040794-001Mar 5, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
METHYLPREDNISOLONE ACETATE
methylprednisolone acetate
INJECTABLE;INJECTION040794-002Mar 5, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
METHYLPREDNISOLONE ACETATE
methylprednisolone acetate
INJECTABLE;INJECTION040620-002Oct 27, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
MEDROL
methylprednisolone acetate
ENEMA;RECTAL018102-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DEPO-MEDROL
methylprednisolone acetate
INJECTABLE;INJECTION011757-004Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Chinese Patent Office
Moodys
Fish and Richardson
Farmers Insurance
Covington
US Department of Justice
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot